Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2008;39:2396-2399
Published online before print June 5, 2008, doi: 10.1161/STROKEAHA.107.505776
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/8/2396    most recent
STROKEAHA.107.505776v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gorelick, P. B.
Right arrow Articles by Pandey, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gorelick, P. B.
Right arrow Articles by Pandey, D. K.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*International Health
*Stroke
Related Collections
Right arrow Other Stroke Treatment - Medical

(Stroke. 2008;39:2396.)
© 2008 American Heart Association, Inc.


Comments, Opinions, and Reviews

Large Artery Intracranial Occlusive Disease

A Large Worldwide Burden but a Relatively Neglected Frontier

Philip B. Gorelick, MD, MPH; Ka Sing Wong, MD; Hee-Joon Bae, MD, PhD Dilip K. Pandey, MD, PhD

From the Center for Stroke Research, Department of Neurology and Rehabilitation (P.B.G.), University of Illinois College of Medicine, Chicago; the Department of Medicine & Therapeutics (K.S.W.), Chinese University of Hong Kong, Hong Kong, China; the Stroke Center (H.J.B.), Seoul National University, Bundang Hospital, and the Department of Neurology, College of Medicine, Seoul National University, Seoul, Korea; and the Neuroepidemiology and Clinical Trials Unit, Department of Neurology and Rehabilitation and Center for Stroke Research (D.K.P.), University of Illinois College of Medicine, Chicago.

Correspondence to Philip B. Gorelick, MD, MPH, John S. Garvin Professor and Head, Director, Center for Stroke Research, Department of Neurology and Rehabilitation, 912 S Wood St, Room 855N, Chicago, IL 60612. E-mail pgorelic{at}uic.edu

Background and Purpose— Large artery intracranial occlusive disease (LAICOD) is a common and important stroke subtype. In this commentary, we review key epidemiological aspects of LAICOD.

Summary of Review— LAICOD has emerged as the most common stroke subtype worldwide and is associated with a high risk of recurrent stroke. Hypotheses have been proposed to explain causation, which include such factors as traditional cardiovascular risk factors, high blood volume states, and genetic abnormalities. Approaches to treatment such as antithrombotic therapies, revascularization procedures, and counterpulsation devices hold promise.

Conclusions— LAICOD poses a major stroke problem worldwide and is likely the most common stroke subtype. The etiology and treatment of this disorder remain poorly defined. International collaborations are needed to pool collective knowledge and develop definitive studies to better understand causation and treatment of LAICOD.


Key Words: intracranial occlusive disease • risk factors • high-risk populations




This article has been cited by other articles:


Home page
StrokeHome page
B. L. Man, Y. P. Fu, Y. Y. Chan, W. Lam, A. C. F. Hui, W. H. Leung, V. Mok, and K. S. Wong
Lesion Patterns and Stroke Mechanisms in Concurrent Atherosclerosis of Intracranial and Extracranial Vessels
Stroke, October 1, 2009; 40(10): 3211 - 3215.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. N. Turan, C. P. Derdeyn, D. Fiorella, and M. I. Chimowitz
Treatment of Atherosclerotic Intracranial Arterial Stenosis
Stroke, June 1, 2009; 40(6): 2257 - 2261.
[Full Text] [PDF]